Actively Recruiting
Excessive Supraventricular Activity and Atrial Fibrillation
Led by Karolinska Institutet · Updated on 2024-03-06
250
Participants Needed
1
Research Sites
276 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
D
Danderyd Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the proposed study is to determine if individuals with excessive supraventricular ectopic activity (ESVEA) on Holter recording should be subjected to prolonged screening with Event loop recorder in order to detect previously undiagnosed Atrial fibrillation / flutter. Other biomarkers such as plasma biomarkers, high-end echocardiography and assessment of blood pressure and atrial stiffness will be studied and compared in ESVEA and control group as well as progression of atrial cardiomyopathy in ESVEA patients.
CONDITIONS
Official Title
Excessive Supraventricular Activity and Atrial Fibrillation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with at least 30 supraventricular extra systole (SVES) per hour or a supraventricular run of at least 20 beats on a Holter recording
You will not qualify if you...
- Age less than 70 years or greater than 89 years
- Atrial fibrillation or atrial flutter
- Lifelong treatment with oral anticoagulants
- Patients with implantable cardiac devices
- Congestive heart failure with ejection fraction 30% or less
- Severe valvular heart disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Danderyd Hospital
Stockholm, Sweden
Actively Recruiting
Research Team
J
Johan Engdahl
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here